2 results
Approved WMOPending
To evaluate the efficacy of AD 923 in comparison to MSIR in the management of breakthrough pain in subjects with malignicies who are taking a stable dose of background opioids.
Approved WMOCompleted
To determine if there is a difference in the pharmacokinetics of low-dose cisplatin with and without prehydration.